 The purpose of this study is to see whether HLA-mismatched donor cells infusion with chemotherapy microtransplantation,MST could increase complete remission CR and improve survival in older patients with acute myeloid leukemia AML,the investigators conducted a prospective, multicenter clinical trial of HLA-mismatched MST to estimate outcomes and toxicities. 